Oliver FitzGerald

29.1k total citations · 3 hit papers
471 papers, 14.6k citations indexed

About

Oliver FitzGerald is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Oliver FitzGerald has authored 471 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 304 papers in Rheumatology, 180 papers in Immunology and 123 papers in Hematology. Recurrent topics in Oliver FitzGerald's work include Spondyloarthritis Studies and Treatments (209 papers), Rheumatoid Arthritis Research and Therapies (206 papers) and Psoriasis: Treatment and Pathogenesis (143 papers). Oliver FitzGerald is often cited by papers focused on Spondyloarthritis Studies and Treatments (209 papers), Rheumatoid Arthritis Research and Therapies (206 papers) and Psoriasis: Treatment and Pathogenesis (143 papers). Oliver FitzGerald collaborates with scholars based in Ireland, United States and United Kingdom. Oliver FitzGerald's co-authors include Barry Bresnihan, Douglas J. Veale, Muhammad Haroon, Phil Gallagher, Philip J. Mease, Robert Winchester, D. Mulherin, Gaye Cunnane, Evelyn P. Murphy and Philip Helliwell and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Oliver FitzGerald

448 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis

2017 421 citations Philip J. Mease, Oliver FitzGerald et al. profile →
Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis

2014 416 citations Phil Gallagher, Oliver FitzGerald et al. profile →
Psoriatic arthritis

2021 190 citations Oliver FitzGerald, Alexis Ogdie et al. profile →

Peers

Countries citing papers authored by Oliver FitzGerald

Since Specialization

Citations

This map shows the geographic impact of Oliver FitzGerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver FitzGerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver FitzGerald more than expected).

Fields of papers citing papers by Oliver FitzGerald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver FitzGerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver FitzGerald. The network helps show where Oliver FitzGerald may publish in the future.

Co-authorship network of co-authors of Oliver FitzGerald

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver FitzGerald. A scholar is included among the top collaborators of Oliver FitzGerald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver FitzGerald. Oliver FitzGerald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical, genetic and omics-based biomarkers that might support the identification of the development of psoriatic arthritis in individuals with psoriasis: a narrative review of the literature 2024 ·RMD Open ·(unknown), (unknown), Laura C. Coates, Stephen R. Pennington, Oliver FitzGerald	1
2	GRAPPA 2023: Major Projects, Key Advances, and Milestones 2024 ·The Journal of Rheumatology ·(unknown), Sibel Zehra Aydın, Laura C. Coates, Lihi Eder, Dafna D. Gladman, Philip Helliwell, Gurjit S. Kaeley, Arthur Kavanaugh, Philip J. Mease, Stephen R. Pennington, Fabian Proft, Enrique R. Soriano, Oliver FitzGerald	1
3	Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting 2023 ·The Journal of Rheumatology ·Beverly Ng, Deepak R. Jadon, Frank Behrens, Maarten de Wit, Oliver FitzGerald, Dafna D. Gladman, Philip J. Mease, D. C. O'SULLIVAN, Stephen R. Pennington, Georg Schett, Vinod Chandran, Kurt de Vlam	1
4	Project Highlights From the GRAPPA 2022 Annual Meeting: Education Initiatives and Axial Involvement in Psoriatic Arthritis 2023 ·The Journal of Rheumatology ·Murat Torğutalp, Dafna D. Gladman, Oliver FitzGerald, Philip J. Mease, Denis Poddubnyy	2
5	Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 Annual Meeting 2023 ·The Journal of Rheumatology ·Alice B. Gottlieb, April W. Armstrong, Oliver FitzGerald, Dafna D. Gladman	1
6	Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis 2022 ·The Journal of Rheumatology ·Erik Lubberts, José U. Scher, Oliver FitzGerald	2
7	Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study 2021 ·The Journal of Rheumatology ·William Tillett, Oliver FitzGerald, Laura C. Coates, Jon Packham, Deepak R. Jadon, Marco Massarotti, (unknown), Suzanne Lane, Paul Creamer, (unknown), Eleanor Korendowych, (unknown), Neil McHugh, Philip Helliwell	9
8	Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study 2021 ·The Journal of Rheumatology ·William Tillett, Oliver FitzGerald, Laura C. Coates, Jon Packham, Deepak R. Jadon, Marco Massarotti, (unknown), Suzanne Lane, Paul Creamer, (unknown), Eleanor Korendowych, (unknown), Neil McHugh, Philip Helliwell	17
9	Evaluation and Validation of a Patient-completed Psoriatic Arthritis Flare Questionnaire 2021 ·The Journal of Rheumatology ·Philip Helliwell, William Tillett, Robin Waxman, Laura C. Coates, (unknown), Oliver FitzGerald, Jon Packham, Neil McHugh	4
10	The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA–B27 Status? 2020 ·Arthritis Care & Research ·Laura C. Coates, Xenofon Baraliakos, Francisco J. Blanco, (unknown), Jürgen Braun, Vinod Chandran, J.L. Fernández-Sueiro, Oliver FitzGerald, Phil Gallagher, Dafna D. Gladman, (unknown), Т. В. Коротаева, Е. Yu. Loginova, Ennio Lubrano, Juan Mulero, J. Pinto-Tasende, Rubén Queiró, Jesús Sanz, Ágnes Szentpétery, Philip Helliwell	50
11	The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates 2020 ·The Journal of Rheumatology ·Ying Ying Leung, William Tillett, Ana‐Maria Orbai, Alexis Ogdie, Lihi Eder, Laura C. Coates, Richard Holland, (unknown), Niti Goel, Philip J. Mease, Vibeke Strand, Oliver FitzGerald, (unknown), Christine A. Lindsay, Kristina Callis Duffin, Dafna D. Gladman	11
12	GRAPPA 2018 Project Report 2019 ·The Journal of Rheumatology ·Niti Goel, Oliver FitzGerald, Dafna D. Gladman, Philip Helliwell, Arthur Kavanaugh, Walter P. Maksymowych, Philip J. Mease, Christopher T. Ritchlin, Laura C. Coates	6
13	The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set 2019 ·The Journal of Rheumatology ·Ying Ying Leung, Ana‐Maria Orbai, Alexis Ogdie, Laura C. Coates, Maarten de Wit, Kristina Callis Duffin, Lihi Eder, Dafna D. Gladman, Niti Goel, Philip J. Mease, Vibeke Strand, Oliver FitzGerald, William Tillett	14
14	Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study 2018 ·Arthritis Research & Therapy ·(unknown), Laura C. Coates, Dafna D. Gladman, Peter Nash, Oliver FitzGerald, Arthur Kavanaugh, Tore K Kvien, Laure Gossec, Vibeke Strand, Lawrence Rasouliyan, Luminita Pricop, Kevin Ding, (unknown), Corine Gaillez	27
15	4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis 2018 ·RMD Open ·Désirée van der Heijde, Atul Deodhar, Oliver FitzGerald, Roy Fleischmann, Dafna D. Gladman, Alice B. Gottlieb, Bengt Hoepken, Lars Bauer, (unknown), Majed Khraishi, Luke Peterson, Anthony Turkiewicz, J. Wollenhaupt, Philip J. Mease	30
16	Remission in psoriatic arthritis—where are we now? 2017 ·Lara D. Veeken ·Laura C. Coates, Philip G. Conaghan, Maria Antonietta D’Agostino, Maarten de Wit, Oliver FitzGerald, Tore K Kvien, Rik Lories, Philip J. Mease, Peter Nash, Georg Schett, Enrique R. Soriano, Paul Emery	14
17	Validation of Prognostic Biomarkers for RA: Testing of 14-3-3 Eta According to the Omeract Soluble Biomarker Criteria 2012 ·Data Archiving and Networked Services (DANS) ·Walter P. Maksymowych, (unknown), Robert Landewé, (unknown), Joan M. Bathon, (unknown), Vivian P. Bykerk, Mikkel Østergaard, Hilde Berner Hammer, (unknown), (unknown), Oliver FitzGerald, Christopher T. Ritchlin, Dafna D. Gladman, Philip J. Mease, (unknown), M. Backhaus, Bernard Combe, (unknown), A. Marotta	2
18	Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers. 2007 ·PubMed ·Barry Bresnihan, Daniëlle M. Gerlag, Terence Rooney, Tom Smeets, Carla A. Wijbrandts, David Boyle, Oliver FitzGerald, Bruce Kirkham, Iain B. McInnes, Malcolm Smith, (unknown), Douglas J. Veale, (unknown)	58
19	Cytokines and inflammatory mediators [24-32] 2005 ·British journal of rheumatology ·Frank Behrens, (unknown), (unknown), Burkhard Möller, Heinfried H. Radeke, Ursula Fearon, Ronan Mullan, Robin Poole, Trevor Markham, Oliver FitzGerald, Barry Bresnihan, Douglas J. Veale	1
20	Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. 1999 ·PubMed ·Peter Youssef, Johannes Roth, Michael Frosch, Patrick Costello, Oliver FitzGerald, Clemens Sorg, Barry Bresnihan	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact